Publications by authors named "Davide Quaresmini"

Claim this Profile
I
Investigational agents for pancreatic neuroendocrine tumors: what clinical progress have we seen in the last 5 years?
Paola Marino, Antonella Argentiero, Davide Quaresmini, Elena Sapuppo, Dalila Tessitore

Expert Opin Investig Drugs· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: The molecular tumor board as a step in cancer patient management: a southern Italian experience.
Stefania Tommasi, Leonarda Maurmo, Alessandro Rizzo, Claudia Carella, Girolamo Ranieri, Davide Quaresmini

Front Med (Lausanne)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular tumor board as a step in cancer patient management: a southern Italian experience.
Stefania Tommasi, Leonarda Maurmo, Alessandro Rizzo, Claudia Carella, Girolamo Ranieri, Davide Quaresmini

Front Med (Lausanne)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of immune checkpoint inhibitors in the first-line treatment for patients with advanced biliary tract cancer: a systematic review and meta-analysis of randomized trials.
Elsa Vitale, Alessandro Rizzo, Lorenza Maistrello, Patrizia Nardulli, Tiziana Talienti, Davide Quaresmini

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare histotypes of epithelial biliary tract tumors: A literature review.
Elena Sapuppo, Oronzo Brunetti, Dalila Tessitore, Giovanni Brandi, Nicola Di Giovanni, Davide Quaresmini

Crit Rev Oncol Hematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma.
Michele Guida, Nicola Bartolomeo, Davide Quaresmini, Pietro Quaglino, Gabriele Madonna

J Transl Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Invasive Disease Event-Free Survival Analysis to Investigate Ki67 Role with Respect to Breast Cancer Patients' Age: A Retrospective Cohort Study.
Raffaella Massafra, Samantha Bove, Daniele La Forgia, Maria Colomba Comes, Vittorio Didonna, Davide Quaresmini

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy.
Sabino Strippoli, Annarita Fanizzi, Davide Quaresmini, Annalisa Nardone, Andrea Armenio

Front Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrochemotherapy as a Trigger to Overcome Primary Resistance to Anti-PD-1 Treatment: A Case Report of Melanoma of the Scalp.
Davide Quaresmini, Alessandra Di Lauro, Livia Fucci, Sabino Strippoli, Ivana De Risi

Front Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma.
Rosalba Buquicchio, Valentina Mastrandrea, Sabino Strippoli, Davide Quaresmini, Michele Guida

Front Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoangiogenesis in Melanoma: An Issue in Biology and Systemic Treatment.
Davide Quaresmini, Michele Guida

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining the Relationship between Circulating CD4- CD8- Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy-Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma.
Sabino Strippoli, Annarita Fanizzi, Antonio Negri, Davide Quaresmini, Annalisa Nardone

Cells· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study.
Michele Guida, Nicola Bartolomeo, Pietro Quaglino, Gabriele Madonna, Jacopo Pigozzo, Davide Quaresmini

Cancers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications.
Mauro Cives, Eleonora Pelle', Davide Quaresmini, Francesca Maria Rizzo, Marco Tucci

Neuroendocrinology· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors.
Mauro Cives, Stefano Partelli, Raffaele Palmirotta, Domenica Lovero, Barbara Mandriani, Davide Quaresmini

Sci Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors.
Mauro Cives, Eleonora Pelle', Davide Quaresmini, Barbara Mandriani, Marco Tucci

Curr Treat Options Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology.
Raffaele Palmirotta, Domenica Lovero, Paola Cafforio, Claudia Felici, Francesco Mannavola, Davide Quaresmini

Ther Adv Med Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).
Raffaele Palmirotta, Domenica Lovero, Erica Silvestris, Claudia Felici, Davide Quaresmini

Cancer Genomics Proteomics· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family.
Raffaele Palmirotta, Domenica Lovero, Luigia Stefania Stucci, Erica Silvestris, Davide Quaresmini

Int J Mol Sci· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a rare nonpathogenic sequence variant (c.1905C>T) of the dihydropyrimidine dehydrogenase gene (DPYD).
Raffaele Palmirotta, Domenica Lovero, Erica Silvestris, Claudia Carella, Claudia Felici, Davide Quaresmini

Int J Biol Markers· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desmoid Tumors in Familial Adenomatous Polyposis.
Maria Laura DE Marchis, Francesco Tonelli, Davide Quaresmini, Domenica Lovero, David Della-Morte

Anticancer Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteotropism of neuroendocrine tumors: role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro.
Mauro Cives, Davide Quaresmini, Francesca Maria Rizzo, Claudia Felici, Stella D'Oronzo

Oncotarget· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK gene alterations in cancer: biological aspects and therapeutic implications.
Raffaele Palmirotta, Davide Quaresmini, Domenica Lovero, Franco Silvestris

Pharmacogenomics· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a Rare Nonpathogenic Methylenetetrahydrofolatereductase (MTHFR) Gene Mutation p.Lys215del in a Southern Italian family.
Raffaele Palmirotta, Domenica Lovero, Erica Silvestris, Valeria Simone, Laura Lanotte, Davide Quaresmini

Hum Mutat· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Genomics of lung adenocarcinoma: pathogenetic significance and clinical applications.].
Raffaele Palmirotta, Silvana Acquafredda, Antonella Argentiero, Claudia Carella, Laura Lanotte, Davide Quaresmini

Recenti Prog Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis